RNA - Avidity Biosciences, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-1.24
|
Rev Est: $2.0M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$74.67
DETAILS
HIGH:
$96.00
LOW:
$72.00
MEDIAN:
$72.00
CONSENSUS:
$74.67
UPSIDE:
2.64%
Market Cap:
11.24B
Volume:
4,503,263
Avg Volume:
2,228,703
52 Week Range:
21.51-73.06
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.93
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
391
IPO Date:
2020-06-12
EPS (TTM):
-4.97
P/E Ratio:
-14.51
Revenue (TTM):
18.75M
Total Assets:
1.96B
Total Debt:
49.25M
Cash & Equiv:
382.52M
Rev Growth (5Y):
22.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
N/A
Debt/Equity:
0.03
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-10 | $-1.27 | $-1.09 | -16.5% | $12.5M | $1.9M | +544.0% |
| 2025-08-07 | $-1.21 | $-0.95 | -27.4% | $3.8M | $1.7M | +128.9% |
| 2025-05-08 | $-0.90 | $-0.88 | -2.3% | $1.6M | $2.6M | -40.1% |
| 2025-02-27 | $-0.80 | $-0.76 | -5.3% | $3.0M | $2.9M | +1.6% |
| 2024-11-07 | $-0.65 | $-0.71 | +8.5% | $2.3M | $4.3M | -45.3% |
| 2024-08-09 | $-0.65 | $-0.76 | +14.5% | $2.0M | $2.6M | -22.5% |
| 2024-05-09 | $-0.79 | $-0.81 | +2.5% | $3.5M | $2.6M | +38.4% |
| 2024-02-28 | $-0.79 | $-0.54 | -46.3% | $2.2M | $12.2M | -82.0% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 18.75M | 10.90M | 9.56M | 9.22M | 9.33M | 6.79M | 2.32M | 379,000 |
| Net Income | (684.63M) | (322.30M) | (212.22M) | (174.00M) | (118.01M) | (44.35M) | (24.73M) | (11.93M) |
| EPS | -4.97 | -2.89 | -2.91 | -3.34 | -2.85 | -2.05 | -0.86 | -0.58 |
| Total Assets | 1.96B | 1.56B | 628.55M | 638.80M | 427.58M | 333.90M | 96.91M | 3.98M |
| Total Debt | 49.25M | 6.80M | 9.85M | 10.69M | 11.73M | 938,000 | 4.94M | 10.32M |
| Cash & Equivalents | 382.52M | 219.87M | 185.08M | 340.40M | 320.45M | 321.46M | 94.58M | 3.09M |
| Operating Cash Flow | (650.44M) | (300.87M) | (119.06M) | (136.27M) | (94.81M) | (37.12M) | 2.49M | (9.65M) |
| Free Cash Flow | (663.76M) | (307.94M) | (123.29M) | (139.09M) | (98.55M) | (38.21M) | 2.25M | (9.70M) |
| FCF per Share | -4.82 | -2.76 | -1.69 | -2.67 | -2.38 | -1.76 | 0.06 | -0.47 |
| Book Value | 1.69B | 1.42B | 500.76M | 578.08M | 381.43M | 306.22M | (65.36M) | (41.13M) |
| Cash & ST Investments | 1.70B | 1.50B | 595.35M | 610.73M | 405.54M | 328.14M | 94.58M | 3.09M |
| ROC Equity | -0.41 | -0.23 | -0.42 | -0.30 | -0.31 | -0.14 | N/A | N/A |